PROtecting Maternal brains from Injury and Stroke (PROMIS): a Single-center Phase 2 Clinical Trial

保护母亲大脑免受损伤和中风 (PROMIS):单中心 2 期临床试验

基本信息

  • 批准号:
    10575711
  • 负责人:
  • 金额:
    $ 24.68万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-03-02 至 2025-02-28
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY/ABSTRACT Preeclampsia (PEC) affects 1 in 20 pregnancies and is a leading cause of severe maternal morbidity and mortality. Life-threatening neurological complications of PEC include intracerebral hemorrhage, cerebral edema, cerebral vasospasm, and ischemic stroke. Most maternal deaths due to PEC-associated cerebrovascular complications occur postpartum. Despite this, clinical research has primarily focused on antepartum blood pressure (BP) treatment, rather than postpartum. Current BP management guidelines for postpartum patients recommend absolute thresholds for treatment, without accounting for factors such as degree or rapidity of change from patients’ baseline BP. Clinicians urgently need better methods to 1) identify individuals at risk for these devastating postpartum complications, and 2) guide BP management using personalized, precise targets optimized for brain protection. Normal brain function requires constant cerebral blood flow (CBF). Cerebral arterioles respond actively in response to fluctuations in BP, protecting the brain from acute injury due to hypo- or hyper-perfusion, a phenomenon known as cerebral autoregulation. Changes in cerebral autoregulation contribute to the pathophysiology of postpartum cerebrovascular complications. In individuals with impaired autoregulation, targeting BP parameters to optimize cerebral perfusion could help reduce the risk of ischemia, elevated intracranial pressure, cerebral edema and intracerebral hemorrhage. Near-infrared spectroscopy (NIRS) is a non-invasive bedside monitoring modality that measures brain tissue oxygenation as a proxy for CBF. The use of NIRS-based autoregulation-guided BP targets improves clinical outcomes in neurologically injured patients. We propose to apply this novel approach to the management of postpartum PEC (within 6 weeks of delivery) in a single-center, Phase II clinical trial, PROMIS (PROtecting Maternal brains from Injury and Stroke). We will use NIRS monitoring to calculate personalized limits of cerebral autoregulation in 20 individuals with postpartum preeclampsia with severe features (Aim 1); and pilot the use of autoregulation-guided BP goals for postpartum preeclampsia with severe features in an additional 20 individuals (Aim 2). We hypothesize that: 1) standard guideline-based BP management for postpartum PEC over 24 hours will result in ≥ 10% of time during which BP exceeds personalized upper or lower limits of autoregulation; 2) more time with BP outside personalized limits of autoregulation will be associated with a) increased neurological symptoms and b) objective evidence of cerebral hypo- or hyper-perfusion by NIRS; and 3) targeted BP management using autoregulation-guided goals will result in fewer neurological symptoms and less time spent outside limits of autoregulation, compared with patients treated according to current guidelines. This novel, high-risk, high-reward trial will be the first early phase interventional neuro-obstetric trial aimed at preventing postpartum maternal death and disability due to neurological causes.
项目总结/摘要 先兆子痫(PEC)影响20例妊娠中的1例,是严重孕产妇发病的主要原因, mortality. PEC的危及生命的神经系统并发症包括脑内出血、脑出血、脑出血和脑出血。 水肿、脑血管痉挛和缺血性中风。大多数产妇死亡是由于与PEC有关的 产后出现脑血管并发症。尽管如此,临床研究主要集中在 产前血压(BP)治疗,而不是产后。现行BP管理指南, 产后患者建议治疗的绝对阈值,而不考虑以下因素, 患者基线BP变化的程度或速度。临床医生迫切需要更好的方法来1)识别 个人在这些毁灭性的产后并发症的风险,和2)指导BP管理使用 针对大脑保护进行了优化的个性化精确目标。正常的大脑功能需要持续的 血流量(CBF)。大脑小动脉对血压波动做出积极反应,保护大脑 由于低灌注或高灌注引起的急性损伤,这种现象称为脑自动调节。变化 在脑自动调节中的作用有助于产后脑血管并发症的病理生理学。在 自动调节受损的个体,针对BP参数优化脑灌注可能有助于 降低缺血、颅内压升高、脑水肿和脑出血的风险。 近红外光谱(NIRS)是一种非侵入性床边监测模式,可测量脑组织 氧合作为CBF的代表。使用基于NIRS的自动调节引导BP目标可改善临床 神经损伤患者的预后。我们建议将这种新的方法应用于管理 产后PEC(分娩后6周内)在单中心、II期临床试验PROMIS(PROtecting 损伤和中风的母体脑)。我们将使用近红外光谱监测来计算个性化的限制, 20例重度产后先兆子痫患者的脑自动调节(目的1); 在一个额外的研究中, 20人(目标2)。我们假设:1)产后PEC的标准指南为基础的血压管理 超过24小时将导致≥ 10%的时间内BP超过个性化的上限或下限, 自动调节; 2)BP超出自动调节的个性化限制的更多时间将与a) 增加的神经症状和B)通过NIRS得到的脑低灌注或高灌注的客观证据;和 3)使用自我调节指导的目标进行有针对性的BP管理将导致更少的神经症状, 与根据当前指南治疗的患者相比,在自动调节限度之外花费的时间更少。 这项新的、高风险、高回报的试验将是第一个早期干预性神经产科试验, 预防产后产妇因神经系统原因死亡和残疾。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Eliza C Miller其他文献

Associations between adverse pregnancy outcomes and cognitive impairment and dementia: a systematic review and meta-analysis
不良妊娠结局与认知障碍和痴呆之间的关联:系统评价和荟萃分析
  • DOI:
    10.1016/j.lanhl.2024.100660
  • 发表时间:
    2024-12-01
  • 期刊:
  • 影响因子:
    14.600
  • 作者:
    Eliza C Miller;Patrick Conley;Mohammad Alirezaei;Katrin Wolfova;Mitzi M Gonzales;Zaldy S Tan;Sarah E Tom;Lynn M Yee;Adam M Brickman;Natalie A Bello
  • 通讯作者:
    Natalie A Bello

Eliza C Miller的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Eliza C Miller', 18)}}的其他基金

Vascular Contributions to Cognitive Impairment after Adverse Pregnancy Outcomes: the nuMoM2b-Heart Health Study
血管对不良妊娠结果后认知障碍的影响:nuMoM2b-心脏健康研究
  • 批准号:
    10559052
  • 财政年份:
    2022
  • 资助金额:
    $ 24.68万
  • 项目类别:
Vascular Contributions to Cognitive Impairment after Adverse Pregnancy Outcomes: the nuMoM2b-Heart Health Study
血管对不良妊娠结果后认知障碍的影响:nuMoM2b-心脏健康研究
  • 批准号:
    10675067
  • 财政年份:
    2021
  • 资助金额:
    $ 24.68万
  • 项目类别:
Vascular Contributions to Cognitive Impairment after Adverse Pregnancy Outcomes: the nuMoM2b-Heart Health Study
血管对不良妊娠结果后认知障碍的影响:nuMoM2b-心脏健康研究
  • 批准号:
    10517965
  • 财政年份:
    2021
  • 资助金额:
    $ 24.68万
  • 项目类别:
Vascular Contributions to Cognitive Impairment after Adverse Pregnancy Outcomes: the nuMoM2b-Heart Health Study
血管对不良妊娠结果后认知障碍的影响:nuMoM2b-心脏健康研究
  • 批准号:
    10275504
  • 财政年份:
    2021
  • 资助金额:
    $ 24.68万
  • 项目类别:
Vascular Contributions to Cognitive Impairment after Adverse Pregnancy Outcomes: the nuMoM2b-Heart Health Study
血管对不良妊娠结果后认知障碍的影响:nuMoM2b-心脏健康研究
  • 批准号:
    10445312
  • 财政年份:
    2021
  • 资助金额:
    $ 24.68万
  • 项目类别:
Pregnancy complications and the development of Alzheimer's disease and related dementias in women in the Adult Changes in Thought study
成人思维变化研究中女性妊娠并发症以及阿尔茨海默病和相关痴呆症的发展
  • 批准号:
    10055554
  • 财政年份:
    2020
  • 资助金额:
    $ 24.68万
  • 项目类别:
Neurovascular Unit Dysfunction in Women with Severe Preeclampsia
严重先兆子痫女性的神经血管单元功能障碍
  • 批准号:
    10186050
  • 财政年份:
    2020
  • 资助金额:
    $ 24.68万
  • 项目类别:
Pregnancy complications and the development of Alzheimer's disease and related dementias in women in the Adult Changes in Thought study
成人思维变化研究中女性妊娠并发症以及阿尔茨海默病和相关痴呆症的发展
  • 批准号:
    10271262
  • 财政年份:
    2020
  • 资助金额:
    $ 24.68万
  • 项目类别:
Neurovascular Unit Dysfunction in Women with Severe Preeclampsia
严重先兆子痫女性的神经血管单元功能障碍
  • 批准号:
    10404069
  • 财政年份:
    2019
  • 资助金额:
    $ 24.68万
  • 项目类别:
Neurovascular Unit Dysfunction in Women with Severe Preeclampsia
严重先兆子痫女性的神经血管单元功能障碍
  • 批准号:
    10622557
  • 财政年份:
    2019
  • 资助金额:
    $ 24.68万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.68万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.68万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 24.68万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.68万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.68万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.68万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.68万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 24.68万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 24.68万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 24.68万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了